Net loss of Hindustan Bio Sciences reported to Rs 0.05 crore in the quarter ended September 2024 as against net profit of Rs 0.07 crore during the previous quarter ended September 2023. There were no Sales reported in the quarter ended September 2024 as against Rs 0.32 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales00.32 -100 OPM %018.75 - PBDT-0.050.07 PL PBT-0.050.07 PL NP-0.050.07 PL Powered by Capital Market - Live News

Hindustan Bio Sciences will hold a meeting of the Board of Directors of the Company on 30 October 2024.Powered by Capital Market - Live News

Hindustan Bio Sciences announced that the 32nd Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live News

Hindustan Bio Sciences announced that the 32th Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live News

Net profit of Hindustan Bio Sciences reported to Rs 0.08 crore in the quarter ended June 2024 as against net loss of Rs 0.12 crore during the previous quarter ended June 2023. Sales reported to Rs 0.41 crore in the quarter ended June 2024. There were no Sales reported during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales0.410 0 OPM %17.070 - PBDT0.08-0.12 LP PBT0.08-0.12 LP NP0.08-0.12 LP Powered by Capital Market - Live News